Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data

被引:0
|
作者
Hong Ki Min [1 ]
Se Hee Kim [1 ]
Jong Han Choi [1 ]
Kyomin Choi [2 ]
Hae-Rim Kim [3 ]
Sang-Heon Lee [3 ]
机构
[1] Department of Internal Medicine, Konkuk University Medical Center
[2] Department of Neurology, Konkuk University Medical Center
[3] Division of Rheumatology, Department of Internal Medicine,Konkuk University School of Medicine
关键词
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Neuropathy is a common chronic complication in type 2 diabetes mellitus(T2DM). Statin and metformin are commonly used medications in T2DM patients, and some studies showed statin-or metformin-induced neuropathy.AIM To evaluate the incidence of neuropathy among patients with T2DM associated with statin and metformin therapies.METHODS Korean Health Insurance Review and Assessment national patient sample data from 2016 and 2017 were used. Patients with T2 DM and no complications were divided into statin/metformin/statin + metformin users and non-users. Neuropathy incidence was defined by International Statistical Classification of Diseases and Related Health Problems, 10 th revision codes and concomitant prescriptions for anticonvulsants or antidepressants. Logistic regression analyses were conducted to examine the associations between statin/metformin/statin + metformin therapies and the incidence of neuropathy. Propensity score(PS) matching was performed on the basis of age, sex and comorbidities.RESULTS Overall, 34964 and 35887 patients with T2DM and no complications were included in the Korean Health Insurance Review and Assessment national patient sample datasets from 2016 and 2017, respectively. Statin therapy was associated with increased risks of neuropathy in 2016 and 2017 [PS-matched odds ratio(OR) = 1.22, 95% confidence interval(CI): 1.08-1.38; PS-matched OR = 1.17, 95%CI: 1.03-1.33, respectively]. Metformin therapy was associated with reduced risks of neuropathy in 2016 and 2017(PS-matched OR = 0.30, 95%CI: 0.21-0.42; PSmatched OR = 0.44, 95%CI: 0.32-0.60, respectively). Combined statin + metformin therapy was not significantly associated with neuropathy in 2016 or 2017(PSmatched OR = 0.85, 95%CI: 0.61-1.19; PS-matched OR = 0.95, 95%CI: 0.66-1.38, respectively).CONCLUSION Statin therapy was associated with enhanced risk of new-onset neuropathy in patients with T2DM, but metformin therapy showed the opposite association.
引用
收藏
页码:10198 / 10207
页数:10
相关论文
共 50 条
  • [31] Prevalence of Vitamin B12 Deficiency and Clinical Neuropathy with Metformin Use in Type 2 Diabetes Mellitus Patients
    Kothiwale, Veerappa
    Chafekar, Nahush D.
    Babaliche, Prakash
    Chougule, Nikhil A.
    DIABETES, 2019, 68
  • [32] Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
    Min, Kyung-Wan
    Ku, Bon Jeong
    Lee, Ji-Hyun
    Kim, Min-Seon
    Ahn, Kyu-Jeung
    Lee, Moon-Kyu
    Kokubo, Satoshi
    Yoshida, Satoshi
    Cho, Hyun-Ji
    Cha, Bong-Soo
    DIABETES & METABOLISM JOURNAL, 2017, 41 (02) : 135 - 145
  • [33] Statin Efficacy in Type 1 and Type 2 Diabetes Mellitus
    Ciriacks, Kevin
    Krishnaswami, Shanthi
    Patel, Shailendra
    Kidambi, Srividya
    DIABETES, 2013, 62 : A165 - A165
  • [34] Severe periodontitis, edentulism and neuropathy in patients with type 2 diabetes mellitus
    Menchaca-Diaz, Rufino
    Bogarin-Lopez, Bernardo
    Alberto Zamudio-Gomez, Miguel
    Cecilia Anzaldo-Campos, Maria
    GACETA MEDICA DE MEXICO, 2012, 148 (01): : 34 - 41
  • [35] Early detection of peripheral neuropathy in patients with diabetes mellitus type 2
    Ahmed W. Fadel
    Amin E. Nawar
    Loai M. Elahwal
    Azza A. Ghali
    Osama A. Ragab
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 60
  • [36] Early detection of peripheral neuropathy in patients with diabetes mellitus type 2
    Fadel, Ahmed W.
    Nawar, Amin E.
    Elahwal, Loai M.
    Ghali, Azza A.
    Ragab, Osama A.
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
  • [37] Prevalence of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus
    Karthikeyan, Aditya
    Manjunath, P. R.
    Latha, A. Tharuni
    Sultana, Sana
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (09) : 2070 - 2074
  • [38] DIABETES Preventing type 2 diabetes mellitus: is metformin the answer?
    Buchanan, Thomas A.
    Xiang, Anny H.
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (05) : 253 - 254
  • [39] Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
    Rachman, Abu
    Sauriasari, Rani
    Syafhan, Nadia Farhanah
    Prawiroharjo, Pukovisa
    Risni, Hindun Wilda
    KESMAS-NATIONAL PUBLIC HEALTH JOURNAL, 2022, 17 (04): : 270 - 278
  • [40] Comparison of Operational Definition of Type 2 Diabetes Mellitus Based on Data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey
    Baek, Jong Ha
    Park, Yong-Moon
    Han, Kyung Do
    Moon, Min Kyong
    Choi, Jong Han
    Ko, Seung-Hyun
    DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 201 - 210